These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 36631153)

  • 1. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study.
    Mizrahi B; Sudry T; Flaks-Manov N; Yehezkelli Y; Kalkstein N; Akiva P; Ekka-Zohar A; Ben David SS; Lerner U; Bivas-Benita M; Greenfeld S
    BMJ; 2023 Jan; 380():e072529. PubMed ID: 36631153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
    Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
    Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Long SARS-CoV-2 Omicron Infection on the Health Care Burden: Comparative Case-Control Study Between Omicron and Pre-Omicron Waves.
    Valdivieso-Martinez B; Lopez-Sanchez V; Sauri I; Diaz J; Calderon JM; Gas-Lopez ME; Lidon L; Philibert J; Lopez-Hontangas JL; Navarro D; Cuenca L; Forner MJ; Redon J
    JMIR Public Health Surveill; 2024 Sep; 10():e53580. PubMed ID: 39226091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
    Taquet M; Dercon Q; Harrison PJ
    Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Cohen K; Ren S; Heath K; Dasmariñas MC; Jubilo KG; Guo Y; Lipsitch M; Daugherty SE
    BMJ; 2022 Feb; 376():e068414. PubMed ID: 35140117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
    Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
    Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-Related Differences in Long-COVID-19 Syndrome.
    Pelà G; Goldoni M; Solinas E; Cavalli C; Tagliaferri S; Ranzieri S; Frizzelli A; Marchi L; Mori PA; Majori M; Aiello M; Corradi M; Chetta A
    J Womens Health (Larchmt); 2022 May; 31(5):620-630. PubMed ID: 35333613
    [No Abstract]   [Full Text] [Related]  

  • 8. Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER program.
    Varma JK; Zang C; Carton TW; Block JP; Khullar DJ; Zhang Y; Weiner MG; Rothman RL; Schenck EJ; Xu Z; Lyman K; Bian J; Xu J; Shenkman EA; Maughan C; Castro-Baucom L; O'Brien L; Wang F; Kaushal R;
    PLoS One; 2024; 19(6):e0282451. PubMed ID: 38843159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
    Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
    Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Daugherty SE; Guo Y; Heath K; Dasmariñas MC; Jubilo KG; Samranvedhya J; Lipsitch M; Cohen K
    BMJ; 2021 May; 373():n1098. PubMed ID: 34011492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
    Xu E; Xie Y; Al-Aly Z
    Lancet Diabetes Endocrinol; 2023 Feb; 11(2):120-128. PubMed ID: 36623520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Youth Mental Health Outcomes up to Two Years After SARS-CoV-2 Infection Long-COVID or Long-Pandemic Syndrome: A Retrospective Cohort Study.
    Bilu Y; Flaks-Manov N; Goldshtein I; Bivas-Benita M; Akiva P; Bodenheimer G; Greenfeld S
    J Adolesc Health; 2023 Oct; 73(4):701-706. PubMed ID: 37389526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
    Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
    Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential reduction of post-acute sequelae of SARS-CoV-2 symptoms via vaccination.
    Vanichkachorn G; Gilman E; Ganesh R; Mueller M; Swift M; Breeher L; Murad MH
    J Investig Med; 2023 Dec; 71(8):889-895. PubMed ID: 37497990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection.
    Tartof SY; Malden DE; Liu IA; Sy LS; Lewin BJ; Williams JTB; Hambidge SJ; Alpern JD; Daley MF; Nelson JC; McClure D; Zerbo O; Henninger ML; Fuller C; Weintraub E; Saydah S; Qian L
    JAMA Netw Open; 2022 Aug; 5(8):e2225657. PubMed ID: 35960522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection.
    Brunvoll SH; Nygaard AB; Fagerland MW; Holland P; Ellingjord-Dale M; Dahl JA; Søraas A
    Int J Infect Dis; 2023 Jan; 126():10-13. PubMed ID: 36375693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptoms and risk factors for long COVID in non-hospitalized adults.
    Subramanian A; Nirantharakumar K; Hughes S; Myles P; Williams T; Gokhale KM; Taverner T; Chandan JS; Brown K; Simms-Williams N; Shah AD; Singh M; Kidy F; Okoth K; Hotham R; Bashir N; Cockburn N; Lee SI; Turner GM; Gkoutos GV; Aiyegbusi OL; McMullan C; Denniston AK; Sapey E; Lord JM; Wraith DC; Leggett E; Iles C; Marshall T; Price MJ; Marwaha S; Davies EH; Jackson LJ; Matthews KL; Camaradou J; Calvert M; Haroon S
    Nat Med; 2022 Aug; 28(8):1706-1714. PubMed ID: 35879616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long COVID after breakthrough SARS-CoV-2 infection.
    Al-Aly Z; Bowe B; Xie Y
    Nat Med; 2022 Jul; 28(7):1461-1467. PubMed ID: 35614233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021.
    Wang W; Kaelber DC; Xu R; Berger NA
    JAMA Oncol; 2022 Jul; 8(7):1027-1034. PubMed ID: 35394485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.